Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Sale #103: Analytical R&D Equipment: HPLC, Capillary Electrophoresis, PCR, Particle Analysis & More! Multiple Locations.

Starting: Oct 15th, 2026 – 7:00am PDT

Ending: Oct 16th, 2026 – 9:00am PDT

Immediately Accepting Bids
mdxhealth Logo
Molecular Diagnostics Laboratory Equipment: Biosafety Cabinets, PCR Workstations, ULT Freezers, Incubators & More! Plano, TX.

Starting: Oct 13th, 2026 – 10:00am CDT

Ending: Oct 20th, 2026 – 11:00am CDT

Immediately Accepting Bids

Past Auctions

Global Online Auction Of Extremely Late Model, State of the Art, Pharmaceutical Processing Equipment Formerly of Arena Pharmaceuticals.

Starting: Sep 13th, 2016 – 7:00am PDT

Ending: Sep 14th, 2016 – 12:00pm PDT

Immediately Accepting Bids
Global Online Auction of Mint Condition, Quality & Late Model Laboratory, R&D and Vivarium Equipment From StemCells, Inc. Newark, CA.

Starting: Jul 19th, 2016 – 7:00am PDT

Ending: Jul 20th, 2016 – 9:00am PDT

Immediately Accepting Bids
Sale #44: Complete Closure of A State of the Art Pharmaceutical Manufacturing Facility Located in Søborg Denmark.

Starting: Sep 13th, 2016 – 7:00am BST

Ending: Sep 15th, 2016 – 9:00am BST

Immediately Accepting Bids
Sale #38: Complete Closure of Two (2) State of the Art Pfizer R&D Facilities: Cambridge, United Kingdom and Strängnäs, Sweden.

Starting: Apr 12th, 2016 – 7:00am BST

Ending: Apr 13th, 2016 – 9:00am BST

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.